0001127602-19-002527.txt : 20190123 0001127602-19-002527.hdr.sgml : 20190123 20190123161220 ACCESSION NUMBER: 0001127602-19-002527 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190118 FILED AS OF DATE: 20190123 DATE AS OF CHANGE: 20190123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Powell Lynne CENTRAL INDEX KEY: 0001631667 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23186 FILM NUMBER: 19537541 MAIL ADDRESS: STREET 1: 4505 EMPEROR BLVD. STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000882796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 621413174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-859-1302 MAIL ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2019-01-18 0000882796 BIOCRYST PHARMACEUTICALS INC BCRX 0001631667 Powell Lynne 4505 EMPEROR BLVD. SUITE 200 DURHAM NC 27703 1 Senior VP - CCO Common Stock 2019-01-18 4 M 0 2000 3.22 A 2000 D Common Stock 2019-01-18 4 S 0 2000 9.40 D 0 D Emp. Stock Option (Right to Buy) 3.22 2019-01-18 4 M 0 2000 0 D 2017-05-23 2026-05-23 Common Stock 2000 91427 D This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2018. /s/ Alane P. Barnes, by power of attorney 2019-01-23